UC San Francisco @UCSF · 28 Aug 2026
After melanoma surgery, Mark Orwig joined a UCSF Health trial testing a personalized mRNA cancer vaccine to reduce the risk of melanoma returning. Federal research funding fueled the early mRNA science that made it possible — keeping Mark on the court. https://t.co/Mo5w3emIHt
1 866Views
7Likes
0Reposts
0Replies
0Quotes
1Bookmarks
Is that a lot?
1.00×vs this author's median1 866 views is typical
40Percentile for this authorof 5 recent posts
0.64×vs 10K–100K median2 896 views is typical
2.53%Reachviews ÷ followers
0.38%Engagement rateof viewers reacted